APO Research
Talk to an analyst

APO RESEARCH · REPORT

Advanced Strain-Engineered Microbial Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Advanced Strain-Engineered Microbial Platform Market Outlook and Growth Opportunities 2026

22 January 2026199 pages

Choose your research edition.

Industry ResearchAdvanced Strain-Engineered Microbial Platform Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Advanced Strain-Engineered Microbial Platform Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Advanced Strain-Engineered Microbial Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Advanced Strain-Engineered Microbial Platform Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Advanced Strain-Engineered Microbial Platform Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Advanced Strain-Engineered Microbial Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Advanced Strain-Engineered Microbial Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Advanced Strain-Engineered Microbial Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Advanced Strain-Engineered Microbial Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Advanced Strain-Engineered Microbial Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Advanced Strain-Engineered Microbial Platform market include Ginkgo Bioworks, Amyris, Zymergen, Codexis, Novozymes, DSM-Firmenich, Evonik, Genomatica and LanzaTech, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Advanced Strain-Engineered Microbial Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Advanced Strain-Engineered Microbial Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Advanced Strain-Engineered Microbial Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Advanced Strain-Engineered Microbial Platform market.

Advanced Strain-Engineered Microbial Platform Segment by Company

Ginkgo Bioworks

Amyris

Zymergen

Codexis

Novozymes

DSM-Firmenich

Evonik

Genomatica

LanzaTech

Conagen

Arzeda

BitBio

Advanced Strain-Engineered Microbial Platform Segment by Type

Escherichia Coli

Yeast (Saccharomyces)

Filamentous Fungi

Bacillus Species

Non-Model / Custom Hosts

Advanced Strain-Engineered Microbial Platform Segment by Application

Pharmaceuticals

Industrial Chemicals

Food & Beverage

Agriculture & AgBio

Materials & Polymers

Others

Advanced Strain-Engineered Microbial Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Advanced Strain-Engineered Microbial Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Advanced Strain-Engineered Microbial Platform key companies, revenue, market share, and recent developments.

3. To split the Advanced Strain-Engineered Microbial Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Advanced Strain-Engineered Microbial Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Advanced Strain-Engineered Microbial Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Advanced Strain-Engineered Microbial Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Strain-Engineered Microbial Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Advanced Strain-Engineered Microbial Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Strain-Engineered Microbial Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Advanced Strain-Engineered Microbial Platform industry.

Chapter 3: Detailed analysis of Advanced Strain-Engineered Microbial Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Advanced Strain-Engineered Microbial Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Advanced Strain-Engineered Microbial Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Advanced Strain-Engineered Microbial Platform Industry Trends Table 2. Advanced Strain-Engineered Microbial Platform Industry Drivers Table 3. Advanced Strain-Engineered Microbial Platform Industry Opportunities and Challenges Table 4. Advanced Strain-Engineered Microbial Platform Industry Restraints Table 5. Global Advanced Strain-Engineered Microbial Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Advanced Strain-Engineered Microbial Platform Revenue Share by Company (2021-2026) Table 7. Global Advanced Strain-Engineered Microbial Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Advanced Strain-Engineered Microbial Platform Key Company Manufacturing Base & Headquarters Table 9. Global Advanced Strain-Engineered Microbial Platform Company, Product Type & Application Table 10. Global Advanced Strain-Engineered Microbial Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Advanced Strain-Engineered Microbial Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Escherichia Coli Table 15. Significant Companies of Yeast (Saccharomyces) Table 16. Significant Companies of Filamentous Fungi Table 17. Significant Companies of Bacillus Species Table 18. Significant Companies of Non-Model / Custom Hosts Table 19. Global Advanced Strain-Engineered Microbial Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Advanced Strain-Engineered Microbial Platform Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Advanced Strain-Engineered Microbial Platform Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Type (2021-2026) Table 23. Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Pharmaceuticals Table 25. Significant Companies of Industrial Chemicals Table 26. Significant Companies of Food & Beverage Table 27. Significant Companies of Agriculture & AgBio Table 28. Significant Companies of Materials & Polymers Table 29. Significant Companies of Others Table 30. Global Advanced Strain-Engineered Microbial Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Advanced Strain-Engineered Microbial Platform Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global Advanced Strain-Engineered Microbial Platform Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Application (2021-2026) Table 34. Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Application (2027-2032) Table 35. Global Advanced Strain-Engineered Microbial Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Advanced Strain-Engineered Microbial Platform Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Region (2021-2026) Table 38. Global Advanced Strain-Engineered Microbial Platform Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Region (2027-2032) Table 40. Global Advanced Strain-Engineered Microbial Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Advanced Strain-Engineered Microbial Platform Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global Advanced Strain-Engineered Microbial Platform Sales Value Market Share by Country (2021-2026) Table 43. Global Advanced Strain-Engineered Microbial Platform Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global Advanced Strain-Engineered Microbial Platform Sales Value Market Share by Country (2027-2032) Table 45. Ginkgo Bioworks Company Information Table 46. Ginkgo Bioworks Business Overview Table 47. Ginkgo Bioworks Advanced Strain-Engineered Microbial Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Ginkgo Bioworks Advanced Strain-Engineered Microbial Platform Product Portfolio Table 49. Ginkgo Bioworks Recent Development Table 50. Amyris Company Information Table 51. Amyris Business Overview Table 52. Amyris Advanced Strain-Engineered Microbial Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Amyris Advanced Strain-Engineered Microbial Platform Product Portfolio Table 54. Amyris Recent Development Table 55. Zymergen Company Information Table 56. Zymergen Business Overview Table 57. Zymergen Advanced Strain-Engineered Microbial Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Zymergen Advanced Strain-Engineered Microbial Platform Product Portfolio Table 59. Zymergen Recent Development Table 60. Codexis Company Information Table 61. Codexis Business Overview Table 62. Codexis Advanced Strain-Engineered Microbial Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Codexis Advanced Strain-Engineered Microbial Platform Product Portfolio Table 64. Codexis Recent Development Table 65. Novozymes Company Information Table 66. Novozymes Business Overview Table 67. Novozymes Advanced Strain-Engineered Microbial Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Novozymes Advanced Strain-Engineered Microbial Platform Product Portfolio Table 69. Novozymes Recent Development Table 70. DSM-Firmenich Company Information Table 71. DSM-Firmenich Business Overview Table 72. DSM-Firmenich Advanced Strain-Engineered Microbial Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. DSM-Firmenich Advanced Strain-Engineered Microbial Platform Product Portfolio Table 74. DSM-Firmenich Recent Development Table 75. Evonik Company Information Table 76. Evonik Business Overview Table 77. Evonik Advanced Strain-Engineered Microbial Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Evonik Advanced Strain-Engineered Microbial Platform Product Portfolio Table 79. Evonik Recent Development Table 80. Genomatica Company Information Table 81. Genomatica Business Overview Table 82. Genomatica Advanced Strain-Engineered Microbial Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Genomatica Advanced Strain-Engineered Microbial Platform Product Portfolio Table 84. Genomatica Recent Development Table 85. LanzaTech Company Information Table 86. LanzaTech Business Overview Table 87. LanzaTech Advanced Strain-Engineered Microbial Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. LanzaTech Advanced Strain-Engineered Microbial Platform Product Portfolio Table 89. LanzaTech Recent Development Table 90. Conagen Company Information Table 91. Conagen Business Overview Table 92. Conagen Advanced Strain-Engineered Microbial Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Conagen Advanced Strain-Engineered Microbial Platform Product Portfolio Table 94. Conagen Recent Development Table 95. Arzeda Company Information Table 96. Arzeda Business Overview Table 97. Arzeda Advanced Strain-Engineered Microbial Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Arzeda Advanced Strain-Engineered Microbial Platform Product Portfolio Table 99. Arzeda Recent Development Table 100. BitBio Company Information Table 101. BitBio Business Overview Table 102. BitBio Advanced Strain-Engineered Microbial Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. BitBio Advanced Strain-Engineered Microbial Platform Product Portfolio Table 104. BitBio Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Advanced Strain-Engineered Microbial Platform Product Image Figure 2. Global Advanced Strain-Engineered Microbial Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Advanced Strain-Engineered Microbial Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Advanced Strain-Engineered Microbial Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Escherichia Coli Image Figure 8. Yeast (Saccharomyces) Image Figure 9. Filamentous Fungi Image Figure 10. Bacillus Species Image Figure 11. Non-Model / Custom Hosts Image Figure 12. Global Advanced Strain-Engineered Microbial Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Advanced Strain-Engineered Microbial Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Type (2021-2032) Figure 15. Pharmaceuticals Image Figure 16. Industrial Chemicals Image Figure 17. Food & Beverage Image Figure 18. Agriculture & AgBio Image Figure 19. Materials & Polymers Image Figure 20. Others Image Figure 21. Global Advanced Strain-Engineered Microbial Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Advanced Strain-Engineered Microbial Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Application (2021-2032) Figure 24. Global Advanced Strain-Engineered Microbial Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America Advanced Strain-Engineered Microbial Platform Sales Value (2021-2032) & (US$ Million) Figure 27. North America Advanced Strain-Engineered Microbial Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe Advanced Strain-Engineered Microbial Platform Sales Value (2021-2032) & (US$ Million) Figure 29. Europe Advanced Strain-Engineered Microbial Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific Advanced Strain-Engineered Microbial Platform Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Advanced Strain-Engineered Microbial Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America Advanced Strain-Engineered Microbial Platform Sales Value (2021-2032) & (US$ Million) Figure 33. South America Advanced Strain-Engineered Microbial Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa Advanced Strain-Engineered Microbial Platform Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Advanced Strain-Engineered Microbial Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Escherichia Coli
  • Yeast (Saccharomyces)
  • Filamentous Fungi
  • Bacillus Species
  • Non-Model / Custom Hosts
Applications
  • Pharmaceuticals
  • Industrial Chemicals
  • Food & Beverage
  • Agriculture & AgBio
  • Materials & Polymers
  • Others
Companies covered
  • Ginkgo Bioworks
  • Amyris
  • Zymergen
  • Codexis
  • Novozymes
  • DSM-Firmenich
  • Evonik
  • Genomatica
  • LanzaTech
  • Conagen
  • Arzeda
  • BitBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Advanced Strain-Engineered Microbial Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Advanced Strain-Engineered Microbial Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Advanced Strain-Engineered Microbial Platform Market Dynamics
  1. 2.1 Advanced Strain-Engineered Microbial Platform Industry Trends
  2. 2.2 Advanced Strain-Engineered Microbial Platform Industry Drivers
  3. 2.3 Advanced Strain-Engineered Microbial Platform Industry Opportunities and Challenges
  4. 2.4 Advanced Strain-Engineered Microbial Platform Industry Restraints
3 Advanced Strain-Engineered Microbial Platform Market by Company
  1. 3.1 Global Advanced Strain-Engineered Microbial Platform Company Revenue Ranking in 2025
  2. 3.2 Global Advanced Strain-Engineered Microbial Platform Revenue by Company (2021-2026)
  3. 3.3 Global Advanced Strain-Engineered Microbial Platform Company Ranking (2024-2026)
  4. 3.4 Global Advanced Strain-Engineered Microbial Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Advanced Strain-Engineered Microbial Platform Company Product Type and Application
  6. 3.6 Global Advanced Strain-Engineered Microbial Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Advanced Strain-Engineered Microbial Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Advanced Strain-Engineered Microbial Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Advanced Strain-Engineered Microbial Platform Market by Type
  1. 4.1 Advanced Strain-Engineered Microbial Platform Type Introduction
  2. 4.1.1 Escherichia Coli
  3. 4.1.2 Yeast (Saccharomyces)
  4. 4.1.3 Filamentous Fungi
  5. 4.1.4 Bacillus Species
  6. 4.1.5 Non-Model / Custom Hosts
  7. 4.2 Global Advanced Strain-Engineered Microbial Platform Sales Value by Type
  8. 4.2.1 Global Advanced Strain-Engineered Microbial Platform Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Advanced Strain-Engineered Microbial Platform Sales Value by Type (2021-2032)
  10. 4.2.3 Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Type (2021-2032)
5 Advanced Strain-Engineered Microbial Platform Market by Application
  1. 5.1 Advanced Strain-Engineered Microbial Platform Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Industrial Chemicals
  4. 5.1.3 Food & Beverage
  5. 5.1.4 Agriculture & AgBio
  6. 5.1.5 Materials & Polymers
  7. 5.1.6 Others
  8. 5.2 Global Advanced Strain-Engineered Microbial Platform Sales Value by Application
  9. 5.2.1 Global Advanced Strain-Engineered Microbial Platform Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Advanced Strain-Engineered Microbial Platform Sales Value by Application (2021-2032)
  11. 5.2.3 Global Advanced Strain-Engineered Microbial Platform Sales Value Share by Application (2021-2032)
6 Advanced Strain-Engineered Microbial Platform Regional Value Analysis
  1. 6.1 Global Advanced Strain-Engineered Microbial Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Advanced Strain-Engineered Microbial Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Advanced Strain-Engineered Microbial Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Advanced Strain-Engineered Microbial Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Advanced Strain-Engineered Microbial Platform Sales Value (2021-2032)
  7. 6.3.2 North America Advanced Strain-Engineered Microbial Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Advanced Strain-Engineered Microbial Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Advanced Strain-Engineered Microbial Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Advanced Strain-Engineered Microbial Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Advanced Strain-Engineered Microbial Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Advanced Strain-Engineered Microbial Platform Sales Value (2021-2032)
  16. 6.6.2 South America Advanced Strain-Engineered Microbial Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Advanced Strain-Engineered Microbial Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Advanced Strain-Engineered Microbial Platform Sales Value Share by Country, 2025 VS 2032
7 Advanced Strain-Engineered Microbial Platform Country-level Value Analysis
  1. 7.1 Global Advanced Strain-Engineered Microbial Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Advanced Strain-Engineered Microbial Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Advanced Strain-Engineered Microbial Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Advanced Strain-Engineered Microbial Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Advanced Strain-Engineered Microbial Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Advanced Strain-Engineered Microbial Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Advanced Strain-Engineered Microbial Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ginkgo Bioworks
  2. 8.1.1 Ginkgo Bioworks Company Information
  3. 8.1.2 Ginkgo Bioworks Business Overview
  4. 8.1.3 Ginkgo Bioworks Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ginkgo Bioworks Advanced Strain-Engineered Microbial Platform Product Portfolio
  6. 8.1.5 Ginkgo Bioworks Recent Developments
  7. 8.2 Amyris
  8. 8.2.1 Amyris Company Information
  9. 8.2.2 Amyris Business Overview
  10. 8.2.3 Amyris Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amyris Advanced Strain-Engineered Microbial Platform Product Portfolio
  12. 8.2.5 Amyris Recent Developments
  13. 8.3 Zymergen
  14. 8.3.1 Zymergen Company Information
  15. 8.3.2 Zymergen Business Overview
  16. 8.3.3 Zymergen Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zymergen Advanced Strain-Engineered Microbial Platform Product Portfolio
  18. 8.3.5 Zymergen Recent Developments
  19. 8.4 Codexis
  20. 8.4.1 Codexis Company Information
  21. 8.4.2 Codexis Business Overview
  22. 8.4.3 Codexis Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Codexis Advanced Strain-Engineered Microbial Platform Product Portfolio
  24. 8.4.5 Codexis Recent Developments
  25. 8.5 Novozymes
  26. 8.5.1 Novozymes Company Information
  27. 8.5.2 Novozymes Business Overview
  28. 8.5.3 Novozymes Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novozymes Advanced Strain-Engineered Microbial Platform Product Portfolio
  30. 8.5.5 Novozymes Recent Developments
  31. 8.6 DSM-Firmenich
  32. 8.6.1 DSM-Firmenich Company Information
  33. 8.6.2 DSM-Firmenich Business Overview
  34. 8.6.3 DSM-Firmenich Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 DSM-Firmenich Advanced Strain-Engineered Microbial Platform Product Portfolio
  36. 8.6.5 DSM-Firmenich Recent Developments
  37. 8.7 Evonik
  38. 8.7.1 Evonik Company Information
  39. 8.7.2 Evonik Business Overview
  40. 8.7.3 Evonik Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Evonik Advanced Strain-Engineered Microbial Platform Product Portfolio
  42. 8.7.5 Evonik Recent Developments
  43. 8.8 Genomatica
  44. 8.8.1 Genomatica Company Information
  45. 8.8.2 Genomatica Business Overview
  46. 8.8.3 Genomatica Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genomatica Advanced Strain-Engineered Microbial Platform Product Portfolio
  48. 8.8.5 Genomatica Recent Developments
  49. 8.9 LanzaTech
  50. 8.9.1 LanzaTech Company Information
  51. 8.9.2 LanzaTech Business Overview
  52. 8.9.3 LanzaTech Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LanzaTech Advanced Strain-Engineered Microbial Platform Product Portfolio
  54. 8.9.5 LanzaTech Recent Developments
  55. 8.10 Conagen
  56. 8.10.1 Conagen Company Information
  57. 8.10.2 Conagen Business Overview
  58. 8.10.3 Conagen Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Conagen Advanced Strain-Engineered Microbial Platform Product Portfolio
  60. 8.10.5 Conagen Recent Developments
  61. 8.11 Arzeda
  62. 8.11.1 Arzeda Company Information
  63. 8.11.2 Arzeda Business Overview
  64. 8.11.3 Arzeda Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Arzeda Advanced Strain-Engineered Microbial Platform Product Portfolio
  66. 8.11.5 Arzeda Recent Developments
  67. 8.12 BitBio
  68. 8.12.1 BitBio Company Information
  69. 8.12.2 BitBio Business Overview
  70. 8.12.3 BitBio Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BitBio Advanced Strain-Engineered Microbial Platform Product Portfolio
  72. 8.12.5 BitBio Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst